Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Bifidobacterium lactis BS01 and Reduced Abdominal Pain

Doses used in studies

CFU/day: 5 billion (median 5 billion, IQR 5 billion–5 billion) — 1 study

Time to effect

Median: 4.3 weeks · IQR 4.3 weeks–4.3 weeks · Range 4.3 weeks–4.3 weeks — Reported in 1 of 1 study

1 of 1 paper

The use of probiotics in healthy volunteers with evacuation disorders and hard stools: a double-blind, randomized, placebo-controlled study.
- 2010-09
- RCT · n = 110
- Journal of clinical gastroenterology 44(Supplement 1)
- - Mario Del Piano
  - Stefania Carmagnola
  - Andrea Anderloni
  - Silvano Andorno
  - Marco Ballarè
  - Marco Balzarini
  - Franco Montino
  - Marco Orsello
  - Michela Pagliarulo
  - Massimo Sartori
  - Roberto Tari
  - Filomena Sforza
  - Lucio Capurso
- PubMed: 20697291
- DOI: 10.1097/mcg.0b013e3181ee31c3
5 Insights on
- Reduced Abdominal Pain
- High evidence
- Large Human Trial
- Clinical
Discomfort items such as ... anal itching, burning, or pain also registered a relevant improvement in the active groups receiving probiotics.
Effect
Beneficial
Effect size
Moderate
Significant
Yes
Dose
5 x 10^9 colony-forming units/d